Radiotherapy Market by Technology, Procedure, Cancer, End User - Global Forecast to 2031

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN RADIOTHERAPY MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3.1 RADIOTHERAPY MARKET OVERVIEW
3.2 RADIOTHERAPY MARKET, BY REGION
3.3 NORTH AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY AND COUNTRY
3.4 GEOGRAPHIC SNAPSHOT OF RADIOTHERAPY MARKET

4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Advancements in radiotherapy treatment
4.2.1.2 AI and automation in treatment planning
4.2.1.3 Increasing government investments and awareness initiatives for cancer care
4.2.2 RESTRAINTS
4.2.2.1 High costs associated with radiotherapy systems such as proton therapy and advanced linear accelerators
4.2.2.2 Limited access to advanced radiotherapy infrastructure and skilled workforce in low- and middle-income countries
4.2.2.3 Shortage of skilled radiation oncologists, medical physicists, and trained technicians
4.2.3 OPPORTUNITIES
4.2.3.1 Emerging markets offer significant growth potential for radiotherapy technologies
4.2.3.2 Integration of radiotherapy with immunotherapy and systemic therapies
4.2.3.3 Growing adoption of outpatient radiotherapy and hypofractionated treatment regimens
4.2.4 CHALLENGES
4.2.4.1 Increasing cybersecurity and data protection challenges in digital radiotherapy ecosystems
4.2.4.2 Patient safety concerns and radiation exposure risks
4.3 UNMET NEEDS
4.4 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 INTENSITY OF COMPETITIVE RIVALRY
5.1.2 BARGAINING POWER OF SUPPLIERS
5.1.3 BARGAINING POWER OF BUYERS
5.1.4 THREAT OF SUBSTITUTES
5.1.5 THREAT OF NEW ENTRANTS
5.2 MACROECONOMIC OUTLOOK
5.2.1 GDP TRENDS AND FORECAST
5.2.2 TRENDS IN GLOBAL RADIOTHERAPY INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.3.1 RESEARCH & DEVELOPMENT
5.3.2 PROCUREMENT & MANUFACTURING
5.3.3 MARKETING, SALES, AND DISTRIBUTION
5.4 ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
5.5.1 AVERAGE SELLING PRICE TREND, BY REGION
5.6 TRADE ANALYSIS
5.6.1 IMPORT DATA (HS CODE 902214)
5.6.2 EXPORT DATA (HS CODE 902214)
5.7 KEY CONFERENCES & EVENTS, 2026-2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9 INVESTMENT & FUNDING SCENARIO
5.10 CASE STUDY ANALYSIS
5.10.1 SBRT’S ROLE IN MINIMIZING RADIATION RISK IN ELDERLY PATIENTS
5.10.2 RADIOTHERAPY FOR BREAST CANCER IN PATIENTS WITH HEREDITARY COPROPORPHYRIA
5.10.3 RADIATION THERAPY TREATMENT FOR TRANSITIONAL CELL CARCINOMA OF DISTAL URETHRA
5.11 IMPACT OF 2025 US TARIFF - RADIOTHERAPY MARKET
5.11.1 KEY TARIFF RATES
5.11.2 PRICE IMPACT ANALYSIS
5.11.3 IMPACT ON COUNTRIES/REGIONS
5.11.4 IMPACT ON END-USE INDUSTRIES

6.1 KEY TECHNOLOGIES
6.1.1 MR-GUIDED ADAPTIVE RADIOTHERAPY
6.1.2 ARTIFICIAL INTELLIGENCE-DRIVEN TREATMENT PLANNING
6.1.3 PROTON AND PARTICLE THERAPY
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 ADVANCED TREATMENT PLANNING SYSTEMS AND AI-ENABLED DECISION SUPPORT
6.2.2 CLOUD-BASED AND REMOTE RADIOTHERAPY PLATFORMS
6.3 PATENT ANALYSIS
6.3.1 INNOVATIONS AND PATENT REGISTRATIONS
6.4 FUTURE APPLICATIONS
6.5 IMPACT OF AI/GEN AI ON RADIOTHERAPY MARKET
6.5.1 TOP USE CASES AND MARKET POTENTIAL
6.5.2 BEST PRACTICES FOLLOWED BY MANUFACTURERS IN RADIOTHERAPY MARKET
6.5.3 CASE STUDIES RELATED TO AI IMPLEMENTATION IN RADIOTHERAPY MARKET
6.5.4 INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.5.5 CLIENT'S READINESS TO ADOPT GENERATIVE AI IN RADIOTHERAPY MARKET
6.6 SUCCESS STORIES AND REAL-WORLD APPLICATIONS

7.1 REGIONAL REGULATIONS AND COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2 INDUSTRY STANDARDS
7.1.2.1 North America
7.1.2.1.1 US
7.1.2.1.2 Canada
7.1.2.2 Europe
7.1.2.3 Asia Pacific
7.1.2.3.1 China
7.1.2.3.2 Japan
7.1.2.3.3 India

8.1 DECISION-MAKING PROCESS
8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 BUYING CRITERIA
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM END-USERS

9.1 INTRODUCTION
9.2 SYSTEMS
9.2.1 INCREASING ADOPTION OF AI-ENABLED AND IMAGE-GUIDED RADIOTHERAPY SYSTEMS TO DRIVE GROWTH
9.3 SOFTWARE & SERVICES
9.3.1 INCREASING ADOPTION OF INTEGRATED ONCOLOGY SOFTWARE PLATFORMS TO SUPPORT MARKET GROWTH

10.1 INTRODUCTION
10.2 EXTERNAL BEAM RADIOTHERAPY
10.2.1 PROSTATE CANCER
10.2.1.1 High incidence rate and efficiency of EBRT in prostate cancer treatment to support growth
10.2.2 BREAST CANCER
10.2.2.1 Therapeutic benefits of EBRT to drive market
10.2.3 LUNG CANCER
10.2.3.1 High prevalence of lung cancer and efficiency of EBRT to drive market
10.2.4 HEAD & NECK CANCER
10.2.4.1 Increasing preference for noninvasive treatment of head & neck cancers to drive market
10.2.5 COLORECTAL CANCER
10.2.5.1 High incidence of colorectal cancer to support market growth
10.2.6 OTHER EBRT APPLICATIONS
10.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
10.3.1 PROSTATE CANCER
10.3.1.1 Precision of brachytherapy to drive market
10.3.2 GYNECOLOGICAL CANCER
10.3.2.1 Availability of alternatives to hinder adoption of brachytherapy
10.3.3 BREAST CANCER
10.3.3.1 Growing adoption of accelerated partial breast irradiation drives breast brachytherapy utilization
10.3.4 CERVICAL CANCER
10.3.4.1 MRI-guided adaptive brachytherapy and AI-enabled planning drive advances in cervical cancer treatment
10.3.5 PENILE CANCER
10.3.5.1 Increasing awareness of organ-preservation strategies to drive market
10.3.6 OTHER IBRT APPLICATIONS

11.1 INTRODUCTION
11.2 EXTERNAL BEAM RADIOTHERAPY
11.2.1 IMAGE-GUIDED RADIOTHERAPY
11.2.1.1 Growing adoption of real-time imaging and adaptive workflows to support market growth
11.2.2 INTENSITY-MODULATED RADIOTHERAPY
11.2.2.1 Growing adoption of hypofractionation and adaptive treatment planning to propel market
11.2.3 PARTICLE THERAPY
11.2.3.1 Advancements in treatment planning systems and expansion of proton therapy facilities to drive adoption
11.2.4 3D CONFORMAL RADIOTHERAPY
11.2.4.1 Continued utilization in resource-constrained settings to support adoption of 3D-CRT
11.2.5 STEREOTACTIC RADIOTHERAPY
11.2.5.1 Expanding clinical applications and hypofractionated treatment approaches to propel adoption
11.2.6 OTHER EBRT PROCEDURES
11.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
11.3.1 LDR BRACHYTHERAPY
11.3.1.1 Low risk of radiation exposure to surrounding tissues to drive adoption
11.3.2 HDR BRACHYTHERAPY
11.3.2.1 Advancements in image-guided planning and dose optimization to drive growth
11.3.3 PDR BRACHYTHERAPY
11.3.3.1 Better radiation safety, easier prospective planning, and precise dose shaping to drive adoption

12.1 INTRODUCTION
12.2 EXTERNAL BEAM RADIOTHERAPY
12.2.1 LINACS
12.2.1.1 Conventional LINACs
12.2.1.1.1 Long treatment duration to limit adoption
12.2.1.2 Stereotactic advanced electron/cobalt-60 LINACs
12.2.1.2.1 CyberKnife
12.2.1.2.1.1 Precise radiation delivery with robotic correction capabilities to drive market
12.2.1.2.2 Gamma Knife
12.2.1.2.2.1 Advancements in precision intracranial radiosurgery to drive adoption
12.2.1.2.3 TomoTherapy
12.2.1.2.3.1 Accurate targeting of tumors and minimization of exposure to surrounding healthy tissues to drive adoption
12.2.1.3 MRI LINACs
12.2.1.3.1 Real-time imaging advantage to propel growth
12.2.2 PARTICLE THERAPY
12.2.2.1 Cyclotrons
12.2.2.1.1 Enhanced outcomes and other advantages to boost adoption
12.2.2.2 Synchrotrons
12.2.2.2.1 Increasing investments in synchrotron facilities to drive market
12.2.2.3 Synchrocyclotrons
12.2.2.3.1 Compact synchrocyclotron innovations support adoption despite infrastructure challenges
12.2.3 CONVENTIONAL COBALT-60 TELETHERAPY
12.2.3.1 Complex dose delivery planning and radiation exposure to limit market adoption
12.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
12.3.1 SEEDS
12.3.1.1 Adverse effects associated with brachytherapy seeds to limit adoption
12.3.2 AFTERLOADERS
12.3.2.1 Proper positioning and better control of isotopes in modern afterloaders to drive demand
12.3.3 IORT SYSTEMS
12.3.3.1 Growing clinical evidence supporting long-term efficacy to drive adoption
12.3.4 APPLICATORS
12.3.4.1 High risk of radiation exposure in manual applicators to limit growth

13.1 INTRODUCTION
13.2 HOSPITALS
13.2.1 INCREASING ADOPTION OF AI-ENABLED AND PRECISION RADIATION THERAPY SOLUTIONS TO DRIVE MARKET
13.3 INDEPENDENT RADIOTHERAPY CENTERS
13.3.1 EXPANSION OF RADIOTHERAPY INFRASTRUCTURE AND COMMUNITY-BASED CANCER CARE TO PROPEL MARKET

14.1 INTRODUCTION
14.2 NORTH AMERICA
14.2.1 US
14.2.1.1 Favorable reimbursement scenario to drive growth
14.2.2 CANADA
14.2.2.1 Favorable initiatives from government and private organizations to boost market
14.3 EUROPE
14.3.1 GERMANY
14.3.1.1 Availability of novel radiotherapy products to drive market
14.3.2 FRANCE
14.3.2.1 Presence of advanced healthcare systems to augment growth
14.3.3 UK
14.3.3.1 Growing adoption of advanced radiotherapy technologies and rising cancer burden to drive market
14.3.4 SPAIN
14.3.4.1 Adoption of advanced radiotherapy technologies to drive market
14.3.5 ITALY
14.3.5.1 Rising adoption of advanced radiotherapy technologies and strong research ecosystem to support market growth
14.3.6 REST OF EUROPE
14.4 ASIA PACIFIC
14.4.1 JAPAN
14.4.1.1 Favorable reimbursement policies to propel market
14.4.2 CHINA
14.4.2.1 Precision oncology investments to drive market
14.4.3 INDIA
14.4.3.1 Growing cancer burden, infrastructure investments, and advanced technology adoption to drive market
14.4.4 SOUTH KOREA
14.4.4.1 Rising investments in heavy-ion therapy infrastructure to propel market
14.4.5 AUSTRALIA
14.4.5.1 Growing cancer cases to fuel market
14.4.6 REST OF ASIA PACIFIC
14.5 LATIN AMERICA
14.5.1 BRAZIL
14.5.1.1 Increasing prevalence of cancer to fuel market
14.5.2 MEXICO
14.5.2.1 Expanding oncology infrastructure and precision radiotherapy adoption to drive growth
14.5.3 REST OF LATIN AMERICA
14.6 MIDDLE EAST & AFRICA
14.6.1 GCC COUNTRIES
14.6.1.1 Increasing investments in advanced oncology infrastructure to propel market
14.6.2 REST OF MIDDLE EAST & AFRICA

15.1 INTRODUCTION
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
15.2.1 KEY PLAYER COMPETITIVE STRATEGIES IN RADIOTHERAPY MARKET, JANUARY 2022-MAY 2026
15.3 REVENUE ANALYSIS, 2021-2025
15.4 MARKET SHARE ANALYSIS, 2025
15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
15.5.1 STARS
15.5.2 EMERGING LEADERS
15.5.3 PERVASIVE PLAYERS
15.5.4 PARTICIPANTS
15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
15.5.5.1 Company footprint
15.5.5.2 Region footprint
15.5.5.3 Technology footprint
15.5.5.4 Application footprint
15.5.5.5 End-user footprint
15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
15.6.1 PROGRESSIVE COMPANIES
15.6.2 RESPONSIVE COMPANIES
15.6.3 DYNAMIC COMPANIES
15.6.4 STARTING BLOCKS
15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
15.6.5.1 Detailed list of key startups/SMEs, 2025
15.6.5.2 Competitive benchmarking of key startups/SMEs, 2025
15.7 COMPANY VALUATION & FINANCIAL METRICS
15.8 BRAND COMPARISON
15.9 COMPETITIVE SCENARIO
15.9.1 PRODUCT LAUNCHES & APPROVALS
15.9.2 DEALS
15.9.3 EXPANSIONS

16.1 KEY PLAYERS
16.1.1 SIEMENS HEALTHINEERS AG
16.1.1.1 Business overview
16.1.1.2 Products/Solutions/Services offered
16.1.1.3 Recent developments
16.1.1.3.1 Product approvals
16.1.1.3.2 Deals
16.1.1.4 The Analyst's View
16.1.1.4.1 Key strengths
16.1.1.4.2 Strategic choices
16.1.1.4.3 Weaknesses & competitive threats
16.1.2 ELEKTA
16.1.2.1 Business overview
16.1.2.2 Products/Solutions/Services offered
16.1.2.3 Recent developments
16.1.2.3.1 Product launches & approvals
16.1.2.3.2 Deals
16.1.2.3.3 Expansions
16.1.2.4 The Analyst's View
16.1.2.4.1 Key strengths
16.1.2.4.2 Strategic choices
16.1.2.4.3 Weaknesses & competitive threats
16.1.3 ACCURAY INCORPORATED
16.1.3.1 Business overview
16.1.3.2 Products/Solutions/Services offered
16.1.3.3 Recent developments
16.1.3.3.1 Product launches & approvals
16.1.3.3.2 Deals
16.1.3.3.3 Expansions
16.1.3.4 The Analyst's View
16.1.3.4.1 Key strengths
16.1.3.4.2 Strategic choices
16.1.3.4.3 Weaknesses & competitive threats
16.1.4 IBA WORLDWIDE
16.1.4.1 Business overview
16.1.4.2 Products/Solutions/Services offered
16.1.4.3 Recent developments
16.1.4.3.1 Products launches
16.1.4.3.2 Deals
16.1.4.4 The Analyst's View
16.1.4.4.1 Key strengths
16.1.4.4.2 Strategic choices
16.1.4.4.3 Weaknesses & competitive threats
16.1.5 VIEWRAY SYSTEMS, INC.
16.1.5.1 Business overview
16.1.5.2 Products/Solutions/Services offered
16.1.5.3 Recent developments
16.1.5.3.1 Product approvals
16.1.5.3.2 Deals
16.1.6 GT MEDICAL TECHNOLOGIES, INC.
16.1.6.1 Business overview
16.1.6.2 Products/Solutions/Services offered
16.1.7 HITACHI HIGH-TECH CORPORATION
16.1.7.1 Business overview
16.1.7.2 Products/Solutions/Services offered
16.1.7.3 Recent developments
16.1.7.3.1 Deals
16.1.8 SUMITOMO HEAVY INDUSTRIES, LTD.
16.1.8.1 Business overview
16.1.8.2 Products/Solutions/Services offered
16.1.9 ZEISS GROUP
16.1.9.1 Business overview
16.1.9.2 Products/solutions/services offered
16.1.9.3 Recent developments
16.1.9.3.1 Products launches
16.1.10 MIM SOFTWARE INC.
16.1.10.1 Business overview
16.1.10.2 Products/Solutions/Services offered
16.1.10.3 Recent developments
16.1.10.3.1 Product launches & approvals
16.1.10.3.2 Deals
16.1.11 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
16.1.11.1 Business overview
16.1.11.2 Products/Solutions/Services offered
16.1.11.3 Recent developments
16.1.11.3.1 Product launches
16.1.11.3.2 Deals
16.1.12 PROVISION HEALTHCARE
16.1.12.1 Business overview
16.1.12.2 Products/Solutions/Services offered
16.1.13 MEVION MEDICAL SYSTEMS
16.1.13.1 Business overview
16.1.13.2 Products/Solutions/Services offered
16.1.13.3 Recent developments
16.1.13.3.1 Product launches & approvals
16.1.13.3.2 Deals
16.1.14 KONINKLIJKE PHILIPS N.V.
16.1.14.1 Business overview
16.1.14.2 Products/Solutions/Services offered
16.1.14.3 Recent developments
16.1.14.3.1 Product launches
16.2 OTHER PLAYERS
16.2.1 SHINVA MEDICAL INSTRUMENT CO., LTD.
16.2.2 BRAINLAB AG
16.2.3 RAYSEARCH LABORATORIES
16.2.4 INTRAOP MEDICAL, INC.
16.2.5 OPTIVUS PROTON THERAPY, INC.
16.2.6 BEBIG MEDICAL
16.2.7 P-CURE
16.2.8 THERAGENICS CORPORATION
16.2.9 PROTOM INTERNATIONAL
16.2.10 DOSISOFT SA
16.2.11 ISOAID, LLC
16.2.12 MAGNETTX ONCOLOGY SOLUTIONS LTD.

17.1 RESEARCH DATA
17.1.1 SECONDARY DATA
17.1.1.1 Objectives of secondary research
17.1.1.2 List of secondary sources
17.1.2 PRIMARY DATA
17.1.2.1 Key data from primary sources
17.1.2.2 Key industry insights
17.2 MARKET ESTIMATION METHODOLOGY
17.2.1 BOTTOM-UP APPROACH
17.2.2 REVENUE MAPPING-BASED MARKET ESTIMATION
17.2.3 USAGE-BASED MARKET ESTIMATION
17.2.4 PRIMARY RESEARCH VALIDATION
17.2.5 TOP-DOWN APPROACH
17.3 DATA TRIANGULATION AND MARKET BREAKDOWN
17.4 MARKET SHARE ASSESSMENT
17.5 RESEARCH ASSUMPTIONS
17.6 RESEARCH LIMITATIONS
17.7 RISK ASSESSMENT
17.7.1 RISK ASSESSMENT ANALYSIS

18.1 DISCUSSION GUIDE
18.2 KNOWLEDGESTORE: THE SUBSCRIPTION PORTAL
18.3 CUSTOMIZATION OPTIONS
18.4 RELATED REPORTS
18.5 AUTHOR DETAILS

TABLE 1 RADIOTHERAPY MARKET: INCLUSION/EXCLUSION DETAILS
TABLE 2 DIFFERENT TYPES OF EXTERNAL BEAM RADIATION THERAPY (EBRT) TECHNIQUES AND ASSOCIATED ADVANTAGES AND DISADVANTAGES
TABLE 3 TREATMENT-RELATED EFFECTS AND TOXICITY CONCERNS
TABLE 4 RADIOTHERAPY MARKET: CURRENT UNMET NEEDS
TABLE 5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
TABLE 6 RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 7 AVERAGE SELLING PRICE TREND OF RADIOTHERAPY SYSTEMS, BY REGION, 2023-2025
TABLE 8 IMPORT DATA FOR HS CODE 902214-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD)
TABLE 9 EXPORT DATA FOR HS CODE 902214-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD)
TABLE 10 RADIOTHERAPY MARKET: KEY CONFERENCES & EVENTS, 2026-2027
TABLE 11 US-ADJUSTED RECIPROCAL TARIFF RATES IN MEDTECH INDUSTRY
TABLE 12 TARIFF-INDUCED PRICE INCREASES FOR HEALTHCARE PRODUCTS
TABLE 13 RADIOTHERAPY MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2020-2026
TABLE 14 KEY CLINICAL TRIALS EVALUATING ARTIFICIAL INTELLIGENCE IN RADIOTHERAPY
TABLE 15 KEY AI USE CASES AND MARKET POTENTIAL IN RADIOTHERAPY MARKET
TABLE 16 KEY CLINICAL CASE STUDIES OF ARTIFICIAL INTELLIGENCE APPLICATIONS IN RADIOTHERAPY
TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 23 CLASS II PRESCRIBED EQUIPMENT CERTIFICATES
TABLE 24 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
TABLE 25 INDIA: MEDICAL DEVICE CLASSIFICATION UNDER CDSCO
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY SYSTEMS
TABLE 27 KEY BUYING CRITERIA FOR RADIOTHERAPY SYSTEMS
TABLE 28 RADIOTHERAPY MARKET: CURRENT UNMET NEEDS
TABLE 29 RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE 2024-2031 (USD MILLION)
TABLE 30 RADIOTHERAPY SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 31 RADIOTHERAPY SOFTWARE & SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 32 RADIOTHERAPY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 33 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 34 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 35 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR PROSTATE CANCER, BY REGION, 2024-2031 (USD MILLION)
TABLE 36 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR BREAST CANCER, BY REGION, 2024-2031 (USD MILLION)
TABLE 37 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR LUNG CANCER, BY REGION, 2024-2031 (USD MILLION)
TABLE 38 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR HEAD & NECK CANCER, BY REGION, 2024-2031 (USD MILLION)
TABLE 39 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR COLORECTAL CANCER, BY REGION, 2024-2031 (USD MILLION)
TABLE 40 OTHER EBRT APPLICATIONS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 41 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 42 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 43 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR PROSTATE CANCER, BY REGION, 2024-2031 (USD MILLION)
TABLE 44 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR GYNECOLOGICAL CANCER, BY REGION, 2024-2031 (USD MILLION)
TABLE 45 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR BREAST CANCER, BY REGION, 2024-2031 (USD MILLION)
TABLE 46 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR CERVICAL CANCER, BY REGION, 2024-2031 (USD MILLION)
TABLE 47 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR PENILE CANCER, BY REGION, 2024-2031 (USD MILLION)
TABLE 48 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR OTHER IBRT APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 49 RADIOTHERAPY MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
TABLE 50 EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 51 EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 52 IMAGE-GUIDED RADIOTHERAPY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 53 INTENSITY-MODULATED RADIOTHERAPY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 54 PARTICLE THERAPY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 55 3D CONFORMAL RADIOTHERAPY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 56 STEREOTACTIC RADIOTHERAPY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 57 OTHER EBRT PROCEDURES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 58 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 59 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 60 LDR BRACHYTHERAPY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 61 HDR BRACHYTHERAPY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 62 PDR BRACHYTHERAPY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 63 RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 64 EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 65 EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 66 LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 67 LINACS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 68 CONVENTIONAL LINACS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 69 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 70 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 71 CYBERKNIFE MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 72 GAMMA KNIFE MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 73 TOMOTHERAPY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 74 MRI LINACS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 75 PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2024-2031 (USD MILLION)
TABLE 76 PARTICLE THERAPY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 77 CYCLOTRONS THERAPY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 78 SYNCHROTRONS THERAPY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 79 SYNCHROCYCLOTRONS THERAPY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 80 CONVENTIONAL COBALT-60 TELETHERAPY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 81 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 82 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 83 SEEDS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 84 AFTERLOADERS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 85 IORT SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 86 APPLICATORS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 87 RADIOTHERAPY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 88 RADIOTHERAPY MARKET FOR HOSPITALS, BY REGION, 2024-2031 (USD MILLION)
TABLE 89 RADIOTHERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 90 RADIOTHERAPY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 91 NORTH AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 92 NORTH AMERICA: RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE, 2024-2031 (USD MILLION)
TABLE 93 NORTH AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 94 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 95 NORTH AMERICA: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 96 NORTH AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 97 NORTH AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2024-2031 (USD MILLION)
TABLE 98 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 99 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 100 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 101 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 102 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 103 NORTH AMERICA: RADIOTHERAPY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 104 US: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 105 US: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 106 US: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 107 US: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 108 CANADA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 109 CANADA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 110 CANADA: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 111 CANADA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 112 EUROPE: RADIOTHERAPY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 113 EUROPE: RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE, 2024-2031 (USD MILLION)
TABLE 114 EUROPE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 115 EUROPE: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 116 EUROPE: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 117 EUROPE: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 118 EUROPE: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2024-2031 (USD MILLION)
TABLE 119 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 120 EUROPE: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 121 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 122 EUROPE: EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 123 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 124 EUROPE: RADIOTHERAPY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 125 GERMANY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 126 GERMANY: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 127 GERMANY: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 128 GERMANY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 129 FRANCE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 130 FRANCE: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 131 FRANCE: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 132 FRANCE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 133 UK: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 134 UK: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 135 UK: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 136 UK: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 137 SPAIN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 138 SPAIN: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 139 SPAIN: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 140 SPAIN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 141 ITALY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 142 ITALY: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 143 ITALY: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 144 ITALY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 145 REST OF EUROPE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 146 REST OF EUROPE: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 147 REST OF EUROPE: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 148 REST OF EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 149 ASIA PACIFIC: RADIOTHERAPY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 150 ASIA PACIFIC: RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE, 2024-2031 (USD MILLION)
TABLE 151 ASIA PACIFIC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 152 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 153 ASIA PACIFIC: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 154 ASIA PACIFIC: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 155 ASIA PACIFIC: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2024-2031 (USD MILLION)
TABLE 156 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 157 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 158 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 159 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 160 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 161 ASIA PACIFIC: RADIOTHERAPY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 162 JAPAN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 163 JAPAN: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 164 JAPAN: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 165 JAPAN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 166 CHINA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 167 CHINA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 168 CHINA: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 169 CHINA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 170 INDIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 171 INDIA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 172 INDIA: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 173 INDIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 174 SOUTH KOREA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 175 SOUTH KOREA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 176 SOUTH KOREA: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 177 SOUTH KOREA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 178 AUSTRALIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 179 AUSTRALIA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 180 AUSTRALIA: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 181 AUSTRALIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 182 REST OF ASIA PACIFIC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 183 REST OF ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 184 REST OF ASIA PACIFIC: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 185 REST OF ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 186 LATIN AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 187 LATIN AMERICA: RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE, 2024-2031 (USD MILLION)
TABLE 188 LATIN AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 189 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 190 LATIN AMERICA: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 191 LATIN AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 192 LATIN AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2024-2031 (USD MILLION)
TABLE 193 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 194 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 195 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 196 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 197 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 198 LATIN AMERICA: RADIOTHERAPY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 199 BRAZIL: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 200 BRAZIL: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 201 BRAZIL: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 202 BRAZIL: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 203 MEXICO: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 204 MEXICO: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 205 MEXICO: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 206 MEXICO: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 207 REST OF LATIN AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 208 REST OF LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 209 REST OF LATIN AMERICA: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 210 REST OF LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 211 MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 212 MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE, 2024-2031 (USD MILLION)
TABLE 213 MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 214 MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 215 MIDDLE EAST & AFRICA: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 216 MIDDLE EAST & AFRICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 217 MIDDLE EAST & AFRICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2024-2031 (USD MILLION)
TABLE 218 MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 219 MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 220 MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 221 MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 222 MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 223 MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 224 GCC COUNTRIES: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 225 GCC COUNTRIES: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 226 GCC COUNTRIES: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 227 GCC COUNTRIES: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 228 REST OF MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 229 REST OF MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 230 REST OF MIDDLE EAST & AFRICA: LINACS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 231 REST OF MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 232 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN RADIOTHERAPY MARKET, JANUARY 2022-MAY 2026
TABLE 233 RADIOTHERAPY MARKET: DEGREE OF COMPETITION
TABLE 234 RADIOTHERAPY MARKET: REGION FOOTPRINT
TABLE 235 RADIOTHERAPY MARKET: TECHNOLOGY FOOTPRINT
TABLE 236 RADIOTHERAPY MARKET: APPLICATION FOOTPRINT
TABLE 237 RADIOTHERAPY MARKET: END-USER FOOTPRINT
TABLE 238 RADIOTHERAPY MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 239 RADIOTHERAPY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 240 RADIOTHERAPY MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MAY 2026
TABLE 241 RADIOTHERAPY MARKET: DEALS, JANUARY 2022-MAY 2026
TABLE 242 RADIOTHERAPY MARKET: EXPANSIONS, JANUARY 2022-MAY 2026
TABLE 243 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
TABLE 244 SIEMENS HEALTHINEERS AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 245 SIEMENS HEALTHINEERS AG: PRODUCT APPROVALS, JANUARY 2022-MAY 2026
TABLE 246 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022-MAY 2026
TABLE 247 ELEKTA: COMPANY OVERVIEW
TABLE 248 ELEKTA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 249 ELEKTA: PRODUCTS LAUNCHES & APPROVALS, JANUARY 2022-MAY 2026
TABLE 250 ELEKTA: DEALS, JANUARY 2022-MAY 2026
TABLE 251 ELEKTA: EXPANSIONS, JANUARY 2022-MAY 2026
TABLE 252 ACCURAY INCORPORATED: COMPANY OVERVIEW
TABLE 253 ACCURAY INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 254 ACCURAY INCORPORATED: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MAY 2026
TABLE 255 ACCURAY INCORPORATED: DEALS, JANUARY 2022-MAY 2026
TABLE 256 ACCURAY INCORPORATED: EXPANSIONS, JANUARY 2022-MAY 2026
TABLE 257 IBA WORLDWIDE: COMPANY OVERVIEW
TABLE 258 IBA WORLDWIDE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 259 IBA WORLDWIDE: PRODUCT LAUNCHES, JANUARY 2022-MAY 2026
TABLE 260 IBA WORLDWIDE: DEALS, JANUARY 2022-MAY 2026
TABLE 261 VIEWRAY SYSTEMS, INC.: COMPANY OVERVIEW
TABLE 262 VIEWRAY SYSTEMS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 263 VIEWRAY SYSTEMS, INC.: PRODUCT APPROVALS, JANUARY 2022-MAY 2026
TABLE 264 VIEWRAY SYSTEMS, INC.: DEALS, JANUARY 2022-MAY 2026
TABLE 265 GT MEDICAL TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 266 GT MEDICAL TECHNOLOGIES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 267 HITACHI HIGH-TECH CORPORATION: COMPANY OVERVIEW
TABLE 268 HITACHI HIGH-TECH CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 269 HITACHI HIGH-TECH CORPORATION: DEALS, JANUARY 2022-MAY 2026
TABLE 270 SUMITOMO HEAVY INDUSTRIES, LTD.: COMPANY OVERVIEW
TABLE 271 SUMITOMO HEAVY INDUSTRIES, LTD.: PRODUCTS/SOLUTIONS/ SERVICES OFFERED
TABLE 272 ZEISS GROUP : COMPANY OVERVIEW
TABLE 273 ZEISS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 274 ZEISS GROUP: PRODUCT LAUNCHES, JANUARY 2022-MAY 2026
TABLE 275 MIM SOFTWARE INC.: COMPANY OVERVIEW
TABLE 276 MIM SOFTWARE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 277 MIM SOFTWARE INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MAY 2026
TABLE 278 MIM SOFTWARE INC.: DEALS, JANUARY 2022-MAY 2026
TABLE 279 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: COMPANY OVERVIEW
TABLE 280 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: PRODUCTS/SOLUTIONS/ SERVICES OFFERED
TABLE 281 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: PRODUCT LAUNCHES , JANUARY 2022-MAY 2026
TABLE 282 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: DEALS, JANUARY 2022-MAY 2026
TABLE 283 PROVISION HEALTHCARE: COMPANY OVERVIEW
TABLE 284 PROVISION HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 285 MEVION MEDICAL SYSTEMS: COMPANY OVERVIEW
TABLE 286 MEVION MEDICAL SYSTEMS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 287 MEVION MEDICAL SYSTEMS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MAY 2026
TABLE 288 MEVION MEDICAL SYSTEMS: DEALS, JANUARY 2022-MAY 2026
TABLE 289 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
TABLE 290 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 291 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES, JANUARY 2022-MAY 2026
TABLE 292 SHINVA MEDICAL INSTRUMENT CO., LTD.: COMPANY OVERVIEW
TABLE 293 BRAINLAB AG: COMPANY OVERVIEW
TABLE 294 RAYSEARCH LABORATORIES: COMPANY OVERVIEW
TABLE 295 INTRAOP MEDICAL, INC.: COMPANY OVERVIEW
TABLE 296 OPTIVUS PROTON THERAPY, INC.: COMPANY OVERVIEW
TABLE 297 BEBIG MEDICAL: COMPANY OVERVIEW
TABLE 298 P-CURE: COMPANY OVERVIEW
TABLE 299 THERAGENICS CORPORATION: COMPANY OVERVIEW
TABLE 300 PROTOM INTERNATIONAL: COMPANY OVERVIEW
TABLE 301 DOSISOFT SA: COMPANY OVERVIEW
TABLE 302 ISOAID, LLC: COMPANY OVERVIEW
TABLE 303 MAGNETTX ONCOLOGY SOLUTIONS LTD.: COMPANY OVERVIEW
TABLE 304 RADIOTHERAPY MARKET: RESEARCH ASSUMPTIONS

FIGURE 1 RADIOTHERAPY MARKET SEGMENTATION AND REGIONAL SCOPE
FIGURE 2 DURATION COVERED
FIGURE 3 MARKET SCENARIO
FIGURE 4 GLOBAL RADIOTHERAPY MARKET, 2024-2031
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN RADIOTHERAPY MARKET, 2022-2026
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF RADIOTHERAPY MARKET
FIGURE 7 HIGH-GROWTH SEGMENTS IN RADIOTHERAPY MARKET, 2026-2031
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN RADIOTHERAPY MARKET DURING FORECAST PERIOD
FIGURE 9 ADVANCEMENTS IN AI AND ADAPTIVE RADIOTHERAPY ENHANCE TREATMENT PRECISION
FIGURE 10 NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARE DURING STUDY PERIOD
FIGURE 11 EXTERNAL BEAM RADIATION THERAPY SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2025
FIGURE 12 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 13 RADIOTHERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14 RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 15 RADIOTHERAPY MARKET: VALUE CHAIN ANALYSIS
FIGURE 16 RADIOTHERAPY MARKET: ECOSYSTEM ANALYSIS
FIGURE 17 AVERAGE SELLING PRICE TREND OF RADIOTHERAPY SYSTEMS, BY REGION, 2023-2025 (USD)
FIGURE 18 IMPORT DATA FOR HS CODE 902214-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025
FIGURE 19 EXPORT DATA FOR HS CODE 902214-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025
FIGURE 20 RADIOTHERAPY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 21 RADIOTHERAPY MARKET: INVESTMENT & FUNDING SCENARIO, 2019-2023
FIGURE 22 RADIOTHERAPY MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023
FIGURE 23 VALUE OF INVESTOR DEALS IN RADIOTHERAPY MARKET, BY KEY PLAYER, 2019-2023
FIGURE 24 PATENT ANALYSIS FOR RADIOTHERAPY MARKET, JANUARY 2016-DECEMBER 2025
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY SYSTEMS
FIGURE 26 KEY BUYING CRITERIA FOR RADIOTHERAPY SYSTEMS
FIGURE 27 NORTH AMERICA: RADIOTHERAPY MARKET SNAPSHOT
FIGURE 28 ASIA PACIFIC: RADIOTHERAPY MARKET SNAPSHOT
FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN RADIOTHERAPY MARKET, 2021-2025
FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN RADIOTHERAPY MARKET, 2025
FIGURE 31 RADIOTHERAPY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 32 RADIOTHERAPY MARKET: COMPANY FOOTPRINT
FIGURE 33 RADIOTHERAPY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 34 EV/EBITDA OF KEY VENDORS
FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 36 RADIOTHERAPY MARKET: BRAND COMPARATIVE ANALYSIS
FIGURE 37 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
FIGURE 38 ELEKTA: COMPANY SNAPSHOT
FIGURE 39 ACCURAY INCORPORATED: COMPANY SNAPSHOT
FIGURE 40 IBA WORLDWIDE: COMPANY SNAPSHOT
FIGURE 41 HITACHI HIGH-TECH CORPORATION: COMPANY SNAPSHOT
FIGURE 42 SUMITOMO HEAVY INDUSTRIES, LTD.: COMPANY SNAPSHOT
FIGURE 43 ZEISS GROUP: COMPANY SNAPSHOT
FIGURE 44 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
FIGURE 45 RESEARCH DESIGN
FIGURE 46 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 48 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 49 RADIOTHERAPY MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
FIGURE 50 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2025)
FIGURE 51 RADIOTHERAPY MARKET: MARKET SIZE ESTIMATION METHODOLOGY
FIGURE 52 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 53 DATA TRIANGULATION METHODOLOGY